Search

Abstract Background Individuals with a Prior Cancer History (PCH) are often excluded from clinical trials. However, a growing body of evidence suggests that prior cancer history does not present adverse outcomes on cancer patients. The evidence on the survival of brain cancer patients in this regard remains widely unknown. Methods We conducted a retrospective cohort study to estimate the prevalence and impact of prior cancer on survival of patients diagnosed with brain cancer. Data of patients who were diagnosed with brain cancer as their first or second primary malignancy between 2000 and 2019 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity Score Matching (PSM) was used to ensure comparable baseline characteristics among the patients. Survival analysis was conducted using the Kaplan–Meier method, as well as multivariate Cox proportional hazard and multivariate competing risk models. Results Out of 42 726 patients, 1189 (2.78%) had PCH. Genitourinary (40.4%), Breast (13.6%), Hematologic and Lymphatic (11.4%), and Gastrointestinal malignancies (11.3%) were the most common types of prior cancer. PCH served as a significant risk factor for Overall Survival (OS) (Adjusted Hazard Ratio [AHR] 1.26; 95% CI [1.15–1.39]; p

Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease. There has been a decline in Pneumocystis jirovecii pneumonia incidence in HIV since the introduction of antiretroviral medications. However, its incidence is increasing in non-HIV immunocompromised patients including those with solid organ transplantation, hematopoietic stem cell transplantation, solid organ tumors, autoimmune deficiencies, and primary immunodeficiency disorders. We aim to review and summarize the etiology, epidemiology, clinical presentation, diagnosis, and management of Pneumocystis jirovecii pneumonia in HIV, and non-HIV patients. HIV patients usually have mild-to-severe symptoms, while non-HIV patients present with a rapidly progressing disease. Induced sputum or bronchoalveolar lavage fluid can be used to make a definitive diagnosis of Pneumocystis jirovecii pneumonia. Trimethoprim-sulfamethoxazole is considered to be the first-line drug for treatment and has proven to be highly effective for Pneumocystis jirovecii pneumonia prophylaxis in both HIV and non-HIV patients. Pentamidine, atovaquone, clindamycin, and primaquine are used as second-line agents. While several diagnostic tests, treatments, and prophylactic regimes are available at our disposal, there is need for more research to prevent and manage this disease more effectively.

Horizontal gene transfer (HGT) has been well documented as a driving force in the evolution of bacteria. It has been shown that a horizontally acquired gene, xoc_2868, involved in the global response against oxidative stress and pathogenicity of Xanthomonas oryzae pv. oryzicola strain BLS256. However, as a transcriptional factor (TF), the regulatory mechanism of XOC_2868 has not yet been revealed. Here, evolutionary analysis suggested XOC_2868 might be co-transferred with its physically proximate downstream genes from a Burkholderiaceae ancestor. Interestingly, RNA-seq data of wild-type (BLS256) and Δxoc_2868 strains under oxidative stress showed that XOC_2868 did not regulate the expression of its adjacent genes, but remarkably influenced the expression of several genes involved in the extracellular polysaccharide (EPS) production and xanthan biosynthesis. Chromatin immunoprecipitation-sequence (ChIP-seq) combined with transcriptome analysis revealed that XOC_2868 directly regulates a cydAB operon, encoding two subunits of cytochrome bd oxidase and involved in redox balance. Consistent with Δxoc_2868 strain, cydA- and cydAB-knockout mutants also showed a higher sensitivity to H2O2 along with a reduced bacterial virulence compared with the wild-type strain. Overall, our findings raise the possibility of regulatory circuit evolution shaped by HGT and driven by selection and reveal a novel regulatory pathway that regulates the expression of cytochrome bd oxidase and thus contributes to the virulence of BLS256.

The potential of information technology has influenced the efficiency and quality of healthcare worldwide. Currently, several republics are incorporating electronic health records (EHRs). Due to reluctance of technological adaptation & implementational complexities, electronic health record systems are not in practice. Due to the emphasis on achieving general compatibility, users may perceive systems as being imposed and providing insufficient customizability, which may exacerbate issues in a setting of national implementation. EHS improves patient safety and confidentiality and ensures operative, effective, well-timed, reasonable, and patient-centred care, all of which substantially impact healthcare quality. Blockchain technology has been used by the EHS system, which supports web-based accessibility and availability. The difficulties of exchanging medical data can now be overcome by consumers using an infrastructure based on cloud computing. A variety of cryptographic approaches have been employed to encrypt and safeguard the data. This review paper aims to highlight the role and impact of blockchain in EHR. The proposed research describes cryptography methods, their classifications, and the challenges associated with EHR to identify gaps and countermeasures.

Simulations were performed under continuous processing conditions using the 2D continuum model to describe the internal state of a multi-solid system, comprising solid particles of different sizes and densities at the same time. The feed consisted of 35 types of solid particle species with five different sizes, 1.70, 1.20, 0.85, 0.60 and 0.35 mm, and seven different densities ranging from 1400 to 2000 kg/m3. The simulations results have been used to plot the concentration profiles of solid particles along the bed height. The concentration profiles of the solid particles depicted that the fine dense particles, 0.60 mm, having density equal to 1900 kg/m3 and terminal velocity 0.058 m/s moved downwards and discharged into the underflow. However, the low-density coarse particles, 1.20 mm, having density equal to 1400 kg/m3 and terminal velocity 0.068 m/s moved upwards and conveyed to the overflow, hence, show a separation process based on the density difference. Furthermore, simulation results showed that the particle species having densities close to the value of the separation relative density exhibited higher concentrations along the system height, and the suspension within the system was mainly composed of these species.

Poor uptake of nutrients not only deteriorates the quality but also the yield of horticultural crops. Among various macro and micronutrients, the role of K, Ca and B is very important. Therefore, balanced application and uptake of K and Ca and B can improve the quality and yield of mango trees. So, a field study was conducted with the hypothesis that combined application of K and Ca along with B would be effective to improve yield and quality of Mango cv. Summer Bahisht (SB) Chaunsa. There were two sources of Ca(CaCl2 and Ca(NO3)2) and three sources of K(KNO3, K2SO4 and K-Citrate) combined with boric acid (BA). All Ca and K sources were applied at the rate of 1% while BA was applied at 0.2%. As compared to control, a significant improvement in fruit set panicle-1 (35.7% and 50.0%), fruit retention (125% and 40%), shelf life (73.3% and 36.6%), total soluble solids (35.1% and 40.6%) and fruit yield (52.5% and 49.2%) in 2016 and 2017 respectively, confirmed the effectiveness of KNO3 (1.0%) + BA (0.2%). Between CaCl2 and Ca(NO3)2, application of Ca (NO3)2 was found more efficacious regarding improvement of quality and yield of SB Chaunsa. It is concluded that to improve the quality and yield of Mango cv. SB Chaunsa, KNO3 (1.0%) + BA (0.2%) is the best nutrients combination, and Ca(NO3)2 is a better option as compared to CaCl2.

Background: Immunotherapy for multiple myeloma (MM) has been the focus in recent years due to its myeloma-specific immune responses. We reviewed the literature on non-Food and Drug Administration (FDA) approved monoclonal antibodies (mAbs) to highlight future perspectives. We searched PubMed, EMBASE, Web of Science, Cochrane Library and ClinicalTrials.gov to include phase I/II clinical trials. Data from 39 studies (1906 patients) were included. Of all the agents, Isatuximab (Isa, anti-CD38) and F50067 (anti-CXCR4) were the only mAbs to produce encouraging results as monotherapy with overall response rates (ORRs) of 66.7% and 32% respectively. Isa showed activity when used in combination with lenalidomide (Len) and dexamethasone (Dex), producing a clinical benefit rate (CBR) of 83%. Additionally, Isa used in combination with pomalidomide (Pom) and Dex resulted in a CBR of 73%. Indatuximab Ravtansine (anti-CD138 antibody-drug conjugate) produced an ORR of 78% and 79% when used in combination with Len-Dex and Pom-Dex, respectively. Conclusions: Combination therapy using mAbs such as indatuximab, pembrolizumab, lorvotuzumab, siltuximab or dacetuzumab with chemotherapy agents produced better outcomes as compared to monotherapies. Further clinical trials investigating mAbs targeting CD38 used in combination therapy are warranted.

This paper studies the diagnosis of twisted blade in a multi stages rotor system using adapted wavelet transform and casing vibration. The common detection method (FFT) is effective only if sever blade faults occurred while the minor faults usually remain undetected. Wavelet analysis as alternative technique is still unable to fulfill the fault detection and diagnosis accurately due to its inadequate time-frequency resolution. In this paper, wavelet is adapted and its time-frequency is improved. Experimental study was undertaken to simulate multi stages rotor system. Results showed that the adapted wavelet analysis is effective in twisted blade diagnosis compared to the conventional one.